Intranasal insulin for the treatment of olfactory dysfunction: a protocol for a systematic review and meta-analysis
Introduction Olfactory dysfunction (OD) is a prevalent nasal affliction that has detrimental effects on the patients’ quality of life and safety. Conventional therapeutic strategies have various limitations such as high costs, prolonged treatment durations and adverse side effects. Intranasal insuli...
Saved in:
| Main Authors: | Xi Chen, Yan Xie, Xiaoquan He, Daili Mou, Feifei Chen, Wanling Cui, Yuezhou Wang, Luyun Jiang |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMJ Publishing Group
2024-11-01
|
| Series: | BMJ Open |
| Online Access: | https://bmjopen.bmj.com/content/14/11/e090554.full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Olfactory dysfunction in COVID-19; Self-report or Olfactory Dysfunction Test?
by: Elham Sahebalzamani, et al.
Published: (2025-10-01) -
Olfactory transport efficiency of the manganese oxide nanoparticles (II) after their single or multiple intranasal administrations
by: A. V. Romashchenko, et al.
Published: (2017-05-01) -
Specific structural changes in Parkinson’s disease-related olfactory dysfunction compared to others forms of olfactory dysfunction
by: Sarah Brosse, et al.
Published: (2024-11-01) -
Current status of research on olfactory dysfunction in COVID-19 patients
by: Na WANG, et al.
Published: (2021-06-01) -
Role of oral corticosteroid and olfactory training for treatment of Post-COVID-19 olfactory dysfunction: Our experiences
by: Santosh Kumar Swain, et al.
Published: (2021-01-01)